Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 3p25 3 Microdeletion Syndrome C5437630
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 3p25 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
3p25 3 Microdeletion Syndrome C5437630
A genetic condition from missing chromosome material at 3p25, linked to developmental delays, distinctive features, and sometimes heart or other organ involvement.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
3p25 3 Microdeletion Syndrome C5437630
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
3p25 3 Microdeletion Syndrome C5437630
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
3p25 3 Microdeletion Syndrome C5437630
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
3p25 3 Microdeletion Syndrome C5437630
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
3p25 3 Microdeletion Syndrome C5437630
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
3p25 3 Microdeletion Syndrome C5437630
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 3p25-3-microdeletion-syndrome-C5437630 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3p25 3 Microdeletion Syndrome C5437630 | Discriminating power |
|---|---|---|---|
| Genital development | XX fetus may have atypical genitalia from maternal androgen exposure, ranging from mild to severe. | Genital atypicality is not the defining feature; findings depend on the deletion and associated anomalies. | High |
| Development and features | Primary issue is sex development; broader developmental delay is not established by this description. | Developmental delay and distinctive features are characteristic, sometimes with organ involvement. | High |
| Cause | Androgens from the pregnant person cross to the fetus; not described as a chromosomal deletion. | Missing chromosome material at 3p25.3; a genetic rather than maternal-androgen condition. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and suspected maternal androgen exposure
The history and phenotype align with an endocrine DSD rather than a microdeletion.
Moderate
Need for hormone and possible surgical planning
Specialist endocrine and DSD care is central; exact treatment is individualized.
Moderate
No syndromic developmental or cardiac pattern is evident
Absence of microdeletion features supports prioritizing the androgen-related diagnosis.
Low
Choose 3p25 3 Microdeletion Syndrome C5437630 when
Developmental delay with distinctive features
This pattern fits the described microdeletion better than isolated genital virilization.
Moderate
Suspected heart or other organ anomalies
Multisystem congenital involvement prompts chromosomal microarray consideration.
Moderate
Family or prenatal concern for a chromosomal deletion
Genetic testing, not androgen history alone, establishes this diagnosis.
High
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3p25 3 Microdeletion Syndrome C5437630 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome studies | 46,XX is part of the named condition; confirm clinically. | Karyotype may be normal because a microdeletion can be missed. | A normal karyotype does not exclude 3p25.3 microdeletion. |
| Chromosomal microarray | Not expected to show 3p25.3 deletion if the androgen mechanism is correct. | Can detect missing material at 3p25.3 when present. | Microarray supports the genetic diagnosis; clinician correlation is required. |
| Endocrine and maternal-androgen evaluation | Assessment seeks a maternal androgen source; no universal cutoff is established here. | Androgen studies are not the primary diagnostic test. | Abnormal hormones suggest exposure but do not alone prove either diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Chronic condition with variable genital effects; long-term outcome is not established here.
- Factors
- Degree of androgen exposure, timing, and specialist management may influence course.
3p25 3 Microdeletion Syndrome C5437630
- Outcome
- Chronic genetic condition with variable developmental and organ effects.
- Factors
- Deletion extent, developmental needs, and organ involvement may influence course.
Time frame: From prenatal or congenital onset into long-term follow-up; exact timelines are not established.
Accurate diagnosis, associated anomalies, and access to multidisciplinary care.
Complications comparison
| Complication | Presentation |
|---|---|
| Genital and reproductive effects | Atypical genital development may need specialist hormone or surgical discussion. Reproductive effects are not established from the supplied description. Decisions should be individualized and deferred to experienced clinicians. |
| Neurodevelopment | Developmental impairment is not established as a core feature. Developmental delay is a linked feature and may need long-term support. Severity varies; exact outcomes are not established here. |
| Organ anomalies | Multisystem anomalies are not described as characteristic. Heart or other organs may be involved in some people. Screening should follow genetics and pediatric specialist advice. |
Patient education highlights
- HighDifferent causes
One condition involves maternal androgens affecting an XX fetus; the other is missing chromosome material at 3p25.3.
- HighSpecialist care
Endocrine, genetics, and pediatric specialists should interpret tests and guide care. Avoid unproven treatments.
- MediumVariable course
Both can be chronic, but features and severity vary. No reliable prognosis or mortality figure is supplied.